Our clients range from multinational corporations to SMEs and university spin-outs – across a variety of healthcare market sectors:

  • Pharmaceuticals: Primary and Speciality Care
  • Rare Diseases/Orphan Drugs
  • Cell-therapies and Regenerative Medicine
  • Medical Devices: Consumables/Disposables and Equipment
  • Diagnostics: Point-of-Care, Imaging and Laboratory services
  • Consumer Healthcare

Our therapeutic category experience includes:

  • Allergy
  • Analgesia/Pain management
  • Cardiovascular/Circulatory
  • Dermatology
  • Diabetes
  • Ophthalmology
  • Gastro-intestinal
  • Infectious disease
  • Intensive Care
  • Neurology
  • Oncology
  • Haematology
  • Respiratory
  • Rheumatology
  • Smoking Cessation
  • Women’s Health
Character presenting stats

Strategic analysis

The collection and analysis of market and patient data, gathering insights and systematically evaluating alternative scenarios to optimise the positioning of a product or intervention.

Recent Projects

  • Early modelling to ascertain asset valuations and pricing strategies
  • Opportunity analysis including qualitative and quantitative research in USA and Europe to determine the development priorities and applications for a novel point-of-care diagnostic device
  • Early stage modelling for assessment of new dermatological technologies in France, UK and USA
  • Strategic assessment and business plan review of in-licensing opportunity for mid-cap pharma client
Brand book

Brand development

The identification and creation of specific attributes and benefits to create a distinctive set of values for a brand.

Recent Projects

  • Market access planning for an image enhancement software company in the management of rheumatoid arthritis and breast cancer
  • Developing a company-wide launch-readiness programme for treatment of neutropenia
  • Strategic positioning of therapy for problem in early pregnancy
Synthesis funnel

Evidence synthesis

The use of techniques to identify the best evidence to address a policy or business-relevant question through the comprehensive assimilation of relevant information.

Recent Projects

  • Systematic review of clinical effectiveness studies in numerous therapeutic categories
  • Review of economic evaluations of dermatological interventions to support an HTA
  • Literature review to characterise the burden of disease in diffuse large B-cell lymphoma
  • Systematic review and analysis to support the case for the use of a surrogate endpoint
  • Needs analysis for treatment in non-small-cell lung cancer (NSCLC)
Markov chain

Health economics

The analysis of issues related to efficiency, effectiveness and value as applied to the topic of healthcare: economics concerns how society allocates its resources among alternative uses.

Recent Projects

  • Strategic health economics and outcomes research (HEOR) consulting in oncology including CAR T-cell therapy
  • Pan-European cost-utility model in chronic obstructive pulmonary disease (COPD)
  • Cost-benefit analysis of programme to assess risk of cardiovascular disease/stroke
  • Economic evaluation in diagnosis and management of osteoarthritis
  • Development of easy to use, compelling, budget impact models (BIMs) for various therapies
CBalancing Value Scales

Pricing and reimbursement

The process of establishing a price and obtaining a positive reimbursement decision of formulary listing status for a product.

Recent Projects

  • Pan-European pricing and reimbursement study for treatment in acute lymphocytic leukaemia
  • Payer assessment/pricing analysis of treatment for prostate cancer
  • Successful Drug Tariff application for NHS reimbursement of a wound care product
  • Successful pricing submission for vitamin a for use in cystic fibrosis
HTA character and people

Health technology assessment

The systematic evaluation of properties, effects, and/or impacts of health technology: a multidisciplinary process to evaluate a healthcare intervention or healthcare technology.

Recent Projects

  • Successful health technology assessment (HTA) submissions e.g. psoriasis (NICE, SMC) and advanced gastric cancer (SMC)
  • NICE approval of the first stem cell technology in UK. Included SLR and additional analysis of data to demonstrate long-term benefit
  • Production of early scientific advice dossiers in oncology for HTA in 3 EU countries
CVD Synthesis diagram

Value communications

The development of clear value propositions, underpinned by the evidence in order to help communicate the unique value of your product or intervention

Recent Projects

  • Publications based on cost-effectiveness analysis to demonstrate value of wound care product in NHS
  • Review to support evidence framework in prostate cancer
  • Development of publication on the applicability of HTA methodology in the evaluation of stem-cell therapies
  • Creation of impactful core/global value dossiers
Man holding radio listening device

Medical communications

The development of expertly written scientific & educational materials which communicate agreed key messages to the appropriate scientific community.

Recent Projects

  • Production of various manuscripts, posters, abstracts and papers for journal publication
  • Series of European satellite meetings in microbiology
  • Series of clinician ‘talking heads’ DVDs
Character with clock and money

Professional & stakeholder engagement

To help clients better understand the needs of key stakeholder groups in order ensure your product or intervention reaches the appropriate patients.

Recent Projects

  • Preceptorship programme in haematopathology
  • Large series of global oncology advisory boards in various tumour sites
  • Series of continuing professional development (CPD) approved educational case study-based meetings in anti-infectives
  • Payer advisory boards, KOL mapping and advocacy development programme in dermatology
  • Case study-based clinician training programme in microbiology
  • Global congress organisation and delegate logistical management in intensive care
Happy man whistling

Patient advocacy

Helping clients to understand and engage effectively with patients and advocacy groups to harness their expert knowledge of disease area to best effect.

Recent Projects

  • Engagement with numerous patient groups for insight gathering and building advocacy